|
Re: A view on google trends for resverlogix
|
2
|
Resverlogix Corp.
|
Sep 28, 2019 07:50PM
|
|
Re: A view on google trends for resverlogix
|
3
|
Resverlogix Corp.
|
Sep 29, 2019 02:52AM
|
|
Re: A whole new level...
|
6
|
Resverlogix Corp.
|
Sep 27, 2019 02:10PM
|
|
Re: A whole slew of expired options reported at Canadianinsider:
|
2
|
Resverlogix Corp.
|
Jul 14, 2018 11:23AM
|
|
Re: A whole slew of expired options reported at Canadianinsider:
|
1
|
Resverlogix Corp.
|
Jul 14, 2018 02:20PM
|
|
Re: A Wing and a Prayer
|
5
|
Resverlogix Corp.
|
Sep 21, 2019 03:59AM
|
|
Re: A Wing and a Prayer
|
4
|
Resverlogix Corp.
|
Sep 21, 2019 04:12AM
|
|
Re: AACR
|
1
|
Zenith Epigenetics
|
Apr 01, 2019 05:52PM
|
|
Re: AACR
|
2
|
Zenith Epigenetics
|
Apr 01, 2019 08:25PM
|
|
Re: AACR 2018
|
3
|
Zenith Epigenetics
|
Mar 06, 2018 03:46AM
|
|
Re: AACR 2018
|
1
|
Zenith Epigenetics
|
Feb 27, 2018 08:43PM
|
|
Re: AACR 2018
|
3
|
Zenith Epigenetics
|
Feb 23, 2018 02:54AM
|
|
Re: AACR April 24-29, 2020 for some Zenith Clinical Trial Results?
|
2
|
Zenith Epigenetics
|
Apr 20, 2020 02:59PM
|
|
Re: AAIC and MD&A
|
4
|
Resverlogix Corp.
|
Jul 25, 2018 12:02PM
|
|
Re: AAIC and MD&A
|
5
|
Resverlogix Corp.
|
Jul 25, 2018 03:08PM
|
|
Re: AAIC and MD&A
|
1
|
Resverlogix Corp.
|
Jul 25, 2018 07:39PM
|
|
Re: ABBV-744 is BD2 specific - worth a read
|
9
|
Resverlogix Corp.
|
Feb 02, 2022 06:53PM
|
|
Re: aberaterone
|
3
|
Zenith Epigenetics
|
Jun 25, 2018 12:25AM
|
|
Re: ACC 2019 Abstracts
|
3
|
Resverlogix Corp.
|
Mar 19, 2019 05:39PM
|
|
Re: According to the TMX website there are only 5 million RVX.WT.A oustanding....
|
3
|
Resverlogix Corp.
|
Jun 20, 2019 05:20PM
|
